![]() |
Name |
1-Docosene
|
Molecular Formula | C22H44 | |
IUPAC Name* |
docos-1-ene
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCC=C
|
|
InChI |
InChI=1S/C22H44/c1-3-5-7-9-11-13-15-17-19-21-22-20-18-16-14-12-10-8-6-4-2/h3H,1,4-22H2,2H3
|
|
InChIKey |
SPURMHFLEKVAAS-UHFFFAOYSA-N
|
|
Synonyms |
1-Docosene; 1599-67-3; docos-1-ene; Docosene; AAM97MY7YB; NSC-78486; Alkenes, C20-24 .alpha.-; UNII-AAM97MY7YB; EINECS 216-490-6; NSC 78486; AI3-36497; 1-Docosene; >99%; EC 216-490-6; DTXSID5029219; CHEBI:84220; BAA59967; NSC78486; LMFA11000312; MFCD00027085; ZINC59674948; AKOS028108465; AS-56237; DB-043441; CS-0213243; D1013; FT-0633694; D89761; Q27157591
|
|
CAS | 1599-67-3 | |
PubChem CID | 74138 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 308.6 | ALogp: | 12.2 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 19 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 22 | QED Weighted: | 0.151 |
Caco-2 Permeability: | -5.033 | MDCK Permeability: | 0.00000710 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.115 |
30% Bioavailability (F30%): | 0.947 |
Blood-Brain-Barrier Penetration (BBB): | 0.033 | Plasma Protein Binding (PPB): | 100.71% |
Volume Distribution (VD): | 3.915 | Fu: | 0.87% |
CYP1A2-inhibitor: | 0.1 | CYP1A2-substrate: | 0.162 |
CYP2C19-inhibitor: | 0.237 | CYP2C19-substrate: | 0.057 |
CYP2C9-inhibitor: | 0.058 | CYP2C9-substrate: | 0.959 |
CYP2D6-inhibitor: | 0.257 | CYP2D6-substrate: | 0.112 |
CYP3A4-inhibitor: | 0.287 | CYP3A4-substrate: | 0.034 |
Clearance (CL): | 4.341 | Half-life (T1/2): | 0.026 |
hERG Blockers: | 0.228 | Human Hepatotoxicity (H-HT): | 0.006 |
Drug-inuced Liver Injury (DILI): | 0.087 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.048 |
Skin Sensitization: | 0.976 | Carcinogencity: | 0.036 |
Eye Corrosion: | 0.996 | Eye Irritation: | 0.938 |
Respiratory Toxicity: | 0.229 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000755 | ![]() |
0.914 | D00AOJ | ![]() |
0.747 | ||
ENC000589 | ![]() |
0.859 | D07ILQ | ![]() |
0.531 | ||
ENC000591 | ![]() |
0.842 | D00FGR | ![]() |
0.495 | ||
ENC000283 | ![]() |
0.813 | D0Z5SM | ![]() |
0.475 | ||
ENC000723 | ![]() |
0.812 | D00STJ | ![]() |
0.459 | ||
ENC000431 | ![]() |
0.812 | D0O1PH | ![]() |
0.444 | ||
ENC000430 | ![]() |
0.812 | D05ATI | ![]() |
0.405 | ||
ENC001176 | ![]() |
0.810 | D0Z5BC | ![]() |
0.351 | ||
ENC000923 | ![]() |
0.787 | D0T9TJ | ![]() |
0.339 | ||
ENC000432 | ![]() |
0.778 | D0P1RL | ![]() |
0.311 |